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Purpose. To compare contrast sensitivity, acquired color vision deficiency, and reading ability in patients with glaucoma at different
stages of the disease and to establish correlations between visual field parameters and visual function scores. Methods. This
prospective cross-sectional study included 121 glaucoma patients. Subjects with a diagnosis of chronic open angle glaucoma were
recruited and classified according to Hodapp-Parrish-Anderson criteria. Patients with severe visual field defects were excluded
because they were older, which could bias the interpretation of visual function tests. Contrast sensitivity was measured using the
Pelli-Robson Chart and the CSV1000E test. Chromatic vision was evaluated using the Farnsworth-panel D15 and the L’Anthony
D15 tests of Vision Color Recorder software. Reading ability was measured using Radner-Vissum test. Results. Contrast sensitivity
(with photopic and mesopic luminance with glare) differed significantly between patients with early and moderate visual field
defects (𝑝 < 0.05). Reading ability scores and results of the chromatic vision tests did not differ significantly between the two
groups. Significant and moderate Spearman correlations between visual field indexes and contrast sensitivity tests were detected.
Conclusions. Contrast sensitivity was significantly worse in patients with moderate glaucoma compared to those with early-stage
glaucoma. Evaluation of visual function in clinical practice provides important information to address a glaucoma patient’s vision
complaints.
1. Introduction
Vision loss due to glaucoma is traditionally described as a
loss of “peripheral vision” [1], although this is not the most
commonly reported symptom. Requiring more light and
blurry vision are the most common complaints of patients
with glaucoma [2].
Even from early stages of the disease, glaucoma patients
often complain of much worse vision than we would expect
based on their good visual acuity; and this apparent discrep-
ancy may be based on the decrease in visual function caused
by glaucoma. Visual ability in low illumination conditions
and the capability to detect low-contrast objects are two
important functions in daily life of patients with peripheral
vision loss due to glaucoma [3]. Recent studies suggest that
glaucoma is also associated with greater self-reported reading
difficulty [4] and modestly lower reading speeds [5]. Color
vision defects in patients with glaucoma, especially along the
blue-yellow axis, are also reported [6].
The goal of this study was to evaluate a large sample
of glaucoma patients at different stages of disease severity
to further investigate contrast sensitivity, color vision, and
reading ability using various psychophysical tests. To the best
of our knowledge, there are no studies that evaluate contrast
sensitivity in glaucoma patients under different lighting con-
ditions (photopic and mesopic with glare condition, which
could resemble night driving). In addition, we evaluated the
correlation between visual function worsening and visual
field damage in glaucoma. Characterizing visual function
in patients with glaucoma (beyond the visual field) may
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Table 1: Hodapp-Parrish-Anderson classification system.
Early defect Moderate defect Severe defect
Mean deviation between 0 and −6 dB, AND
at least one of the following listed criteria:
Mean deviation between −6 and −12 dB,
AND at least one of the following listed
criteria:
Mean deviation < −12 dB, AND at least one
of the following listed criteria:
(i) A cluster of ≥3 points on the pattern
deviation plot in an expected location of the
visual field depressed below the 5% level, at
least one of which is depressed below the 1%
level, OR
(ii) Pattern standard deviation significant at
𝑝 < 0.05, OR
(iii) Glaucoma Hemifield Test = Outside
Normal Limits.
(i) ≥25% but <50% of points on the pattern
deviation plot depressed below the 5% level,
and ≥15% but <25% of points depressed
below the 1% level, OR
(ii) At least 1 point within the central 5∘ with
sensitivity of <15 dB, but no points in the
central 5∘ can have a sensitivity of 0 dB, OR
(iii) Only one hemifield may have a point
with sensitivity of <15 dB within 5∘ of
fixation.
(i) ≥50% but <75% of points on pattern
deviation plot depressed below the 5% level
and ≥25% but <50% of points depressed
below the 1% level, OR
(ii) At least one point in the central 5∘ has a
sensitivity of 0 dB, OR
(iii) Points within the central 5∘ with
sensitivity <15 dB in both hemifields.
dB: decibels.
be useful toward enhancing our knowledge and developing
potential methods for enhancing vision-related function in
these patients.
2. Materials and Methods
The local ethics committee approved the study procedure,
which was conducted in accordance with the Declaration of
Helsinki. Informed consent was obtained from all partici-
pants.
2.1. Study Subjects. All glaucoma patients were recruited
from the Glaucoma Department at the Miguel Servet Uni-
versity Hospital (Zaragoza, Spain).
Inclusion criteria included a clinical diagnosis of glau-
coma at a previous visit at least 1 year before. Patients with
primary open angle glaucoma, normal-tension glaucoma,
pseudoexfoliative glaucoma, or pigment dispersion glaucoma
were included. A diagnosis of glaucoma was based on
characteristic optic nerve damage on slit-lamp examination
(defined as a definite notch in the neuroretinal rim or absence
of the neuroretinal rim not due to another known cause)
with corresponding visual field defects. Only eyes with best
corrected visual acuity (BCVA) of 20/30 or better based on
the Snellen chart were included.
Subjects were excluded if they had vision loss secondary
to another eye condition, had any laser procedure in the
previous month, or had any ocular surgery in the previous 3
months. Other exclusion criteria included extreme refractive
errors such as high myopia (−5.0 or higher), hyperopia (+5.0
or higher), or astigmatism (±3.0 or higher) or acute angle
closure glaucoma, congenital color vision defects, or history
of stroke or neurologic pathology. Patients with clinically
significant lenticular opacity using the LOCS III classification
[7] were also excluded. The exclusion criteria for lenticular
opacity were nuclear color/opalescence greater than NC2
and NO2, respectively, cortical cataract greater than C2,
and posterior subcapsular cataract greater than or equal to
P1.
2.2. Ophthalmological Examination. The ocular examina-
tion included measurements of BCVA using ETDRS Charts
(Precision Vision, IL, USA) at 4m with decimal Snellen
visual acuity notation and intraocular pressure (IOP) (using
a calibrated Goldmann applanation tonometer), slit-lamp
examination of the anterior segment, and fundus evaluation.
Given the influence of pupil size in psychophysical testing
[8], horizontal pupil diameter measurements were obtained
using a Colvard pupillometer (Oasis Medical, Glendora, Cal-
ifornia) in photopic lighting at 120 candelas/m2 (cd/m2). The
Humphrey 24-2 Swedish Interactive Threshold Algorithm
Standard perimeter (Zeiss Meditec, Dublin, CA) was used to
evaluate the visual field. All enrolled subjects were classified
according to two stages of visual field damage using the
Hodapp-Parrish-Anderson criteria [9]: early and moderate
defects (Table 1). Patients with severe defects were excluded
because they were older, which could bias the interpretation
of visual function tests.
2.3. Contrast Sensitivity Evaluation. The Pelli-Robson chart
test and the CSV-1000E were used to evaluate contrast sensi-
tivity. The Pelli-Robson test is a contrast sensitivity test with
8 lines and 16 levels of horizontal capital letters measuring
central vision. Each set of three letters on the chart becomes
progressively lower in contrast relative to the background.
Each eye is evaluated separately with the nontested eye
occluded. The chart is mounted on a white wall with the
patient sitting 1 meter away from the chart; the luminance
of the test is photopic, at 120 cd/m2, with the accepted range
being between 60 and 120 cd/m2 [10].
The CSV-1000E chart (Vector Vision, Haag-Streit, Har-
low, UK) is a contrast sensitivity chart test with four rows
of sine-wave gratings. At the recommended test distance of
2.5m, these gratings test the spatial frequencies of 3, 6, 12, and
18 cycles/degree (cpd) to establish a functional acuity score
for patients under nonglare and glare conditions [11]. Each
eye is evaluated separately with the nontested eye occluded. A
functional acuity score can be obtained directly from the test-
scoring sheet, and log values were selected. Ambient lighting
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used to conduct the test was photopic (120 cd/m2) without
glare and mesopic (0.8 cd/m2) with glare condition (after
10min of dark adaptation, at 0.8 cd/m2).
2.4. Color Vision Evaluation. The Farnsworth-panel D15 (F-
D15) and the L’Anthony desaturated D15 (L-D15) tests of
Vision Color Recorder software (Optical Diagnosis, Inc.,
Beusichem, Netherlands) were performed in all the study
subjects using the best corrected refraction for near sight
under specific photopic lighting (120 cd/m2) and at a 45∘
angle to the screen. Each eye was evaluated separately with
the nontested eye occluded. F-D15 and L-D15 are both
arrangement tests in which the subject is offered a series of
colors that need to be sorted either into a sequence (usually
based on hue) or into groups (most often grays versus colors).
The L-D15 test is more sensitive than the F-D15 test for
detecting color vision impairment. Therefore, a subject who
passes the F-D15 test but fails the L-D15, which has smaller
color differences, may have a mild defect in chromatic vision.
For grading acquired color vision defects, we used the
Confusion Color Index (CCI) developed by Bowman [12].
CCI assesses the severity of dyschromatopsia. A CCI score
higher than 1 indicates altered color vision perception; the
higher the score, the worse the condition.
2.5. Reading Ability Evaluation. Radner et al. developed the
Radner reading charts, which are based on the concept of
using sentence optotypes for the standardized examination of
reading acuity and reading speed [13].The Spanish version of
the Radner reading charts, Radner-Vissum test, was adminis-
tered to all of the study patients binocularly [14]. The reading
distance was 40 cm. A standard luminance of 80 cd/m2 was
used.
The parameters registered were LogRAD score and max-
imum reading speed (MRS) in words per minute (wpm).
LogRAD score is a correction of the reading acuity (LogRAD)
for the number of reading errors (LogRAD score = LogRAD
+ 0.005 × syllables of incorrectly read words). The reading
speed was calculated based on the number of words in a
sentence and the time needed to read the sentence (14words×
60 seconds divided by the reading time = words per minute).
The mean reading speed of the subsequent sentences up to
the Critical Print Size was defined as the MRS. The Critical
Print Size is the print size at which reading speed begins to
deteriorate; after calculating the reading speed per sentence
(wpm), this was plotted on a graph and the print size where
the line suddenly dropped was defined as the Critical Print
Size.
2.6. Statistical Analysis. This was an observational, prospec-
tive cross-sectional study. A total of 121 eyes of 121 patients
were included in the statistical analysis. One eye from
each subject was randomly chosen for the study, unless
only one eye met the inclusion criteria. All 121 eyes were
stratified according to the severity of glaucomatous damage
in two stages (early andmoderate defects) followingHodapp-
Parrish-Anderson criteria [9] (Table 1). All data analyses were
performed using SPSS version 20.0 (SPSS Incorporation,
Table 2: Descriptive and clinical data for 121 glaucoma patients
classified into two groups according to disease severity (Hodapp-
Parrish-Anderson criteria).
Early defect
(𝑛 = 94)
Moderate defect
(𝑛 = 27) ∗𝑝
Mean ± SD Mean ± SD
Age (years) 65.13 ± 9.37 66.44 ± 10.03 0.253
BCVA (decimal
notation) 1.07 ± 0.23 0.94 ± 0.20 0.016
IOPb (mm Hg) 22.03 ± 2.86 22.37 ± 3.80 0.647
CDR 0.58 ± 0.19 0.75 ± 0.17 <0.001
MD (dB) −1.95 ± 1.42 −8.74 ± 1.79 <0.001
PSD (dB) 2.19 ± 1.31 8.98 ± 2.49 <0.001
VFI (%) 97.23 ± 3.02 78.08 ± 6.22 <0.001
CP (𝜇m) 552.72 ± 41.80 545.92 ± 32.49 0.239
Photopic pupil size
(mm) 3.29 ± 0.78 3.27 ± 0.63 0.803
∗𝑝: level of statistical significance in comparison between groups using
the Mann-Whitney nonparametric test. Bold text shows the statistically
significant results (𝑝 < 0.05).
BCVA: best corrected visual acuity; IOPb: basal intraocular pressure; CDR:
cup-to-disc ratio; MD, PSD, and VFI, mean deviation (MD), pattern stan-
dard deviation (PSD), and visual field index (VFI) obtained in the visual field
using Humphrey 24-2 Swedish Interactive Threshold Algorithm Standard
perimeter; dB: decibels; CP: corneal pachymetry; 𝜇m: micrometers; SD:
standard deviation.
Chicago, IL) statistical software. The Kolmogorov-Smirnov
test was used to assess sample distribution. Due to the non-
parametric distribution of the data, the results were compared
using the Mann-Whitney nonparametric test. Correlations
were examined by Spearman’s test. A 𝑝 value of 0.05 was
considered statistically significant.
3. Results
One hundred and twenty-one eyes of 121 glaucoma patients
were examined (94 eyes with early defects and 27 with
moderate defects). Epidemiologic and disease characteristics
of each of the two groups of patients are shown in Table 2.
Sixty-four patients were females (52.9%) and 57 were males
(47.1%). The two groups did not differ with respect to age or
sex. Pupil size did not differ between the groups.
The visual function results are summarized in Table 3.The
contrast sensitivity evaluation indicated statistical differences
of the Pelli-Robson and CSV1000E parameters (photopic
luminance; all frequencies) between patients with early and
moderate defects (𝑝 < 0.05). The CSV1000E test performed
with mesopic luminance and glare conditions also revealed
statistically significant differences in all frequencies except 12
cpd between patients with early and moderate defects (𝑝 <
0.05). Our analysis revealed no significant differences in color
vision and reading ability between the early and moderate
defect groups.
Correlations between visual field indexes and contrast
sensitivity tests were moderate and statistically significant
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Table 3: Mean and standard deviation obtained in visual function
tests with subjects classified into two groups according to disease
severity (Hodapp-Parrish-Anderson criteria).
Early defect
(𝑛 = 94)
Moderate
defect
(𝑛 = 27) 𝑝
∗
Mean ± SD Mean ± SD
Pelli-Robson (F) 1.76 ± 0.18 1.51 ± 0.30 <0.001
CSV (F) 3 cpd 1.70 ± 0.22 1.51 ± 0.26 0.003
CSV (F) 6 cpd 1.87 ± 0.24 1.68 ± 0.29 0.003
CSV (F) 12 cpd 1.45 ± 0.30 1.24 ± 0.37 0.022
CSV (F) 18 cpd 1.02 ± 0.32 0.73 ± 0.35 0.002
CSV (M + G) 3 cpd 1.48 ± 0.31 1.25 ± 0.34 0.001
CSV (M + G) 6 cpd 1.29 ± 0.56 0.88 ± 0.61 0.003
CSV (M + G) 12 cpd 0.73 ± 0.56 0.46 ± 0.42 0.062
CSV (M + G) 18 cpd 0.40 ± 0.39 0.18 ± 0.21 0.020
LogRad score (RV) 0.09 ± 0.10 0.11 ± 0.15 0.668
MRS (wpm) 195.6 ± 36.1 189.4 ± 62.1 0.110
CCI F-D15 1.16 ± 0.24 1.12 ± 0.20 0.733
CCI L-D15 1.36 ± 0.33 1.43 ± 0.27 0.173
∗𝑝: level of statistical significance in comparison between groups using
Mann-Whitney nonparametric test. Bold text shows the statistically signifi-
cant results (𝑝 < 0.05).
RV: Radner-Vissum reading test; MRS: maximum reading speed; wpm:
words per minute; F: photopic luminance; CSV: CSV1000E contrast sensi-
tivity test; M + G: mesopic luminance with glare condition; cpd: cycles per
degree (spatial frequency); CCI: confusion color index; F-D15: Farnsworth-
panel D15; L-D15: L’Anthony desaturated D15; SD: standard deviation.
(Table 4). The highest correlations were between the Pelli-
Robson results and mean deviation (𝑟 = 0.43, 𝑝 < 0.001);
Pelli-Robson and pattern standard deviation (𝑟 = −0.48,
𝑝 < 0.001); and Pelli-Robson and visual field index (𝑟 =
0.38, 𝑝 < 0.001). Correlations were lower (𝑟 absolute value
ranged between 0.25 and 0.39), but statistically significant,
between almost all variables of the visual field indexes
(especiallymean deviation) andCSV1000E results performed
in photopic luminance and mesopic luminance with glare,
with the best correlations in the low frequencies (3 and 6
cpd). Visual field indexes and reading ability results were
not significantly correlated. The visual field indexes and
CCI were not significantly correlated, except for pattern
standard deviation and CCI of L-D15 with a significant weak
correlation (𝑟 = 0.21, 𝑝 = 0.019).
4. Discussion
Although visual field measurement and optic disc evaluation
are the principal methods for confirming the presence and
progression of glaucoma, psychophysical tests to examine
the function of specific parts of the visual pathway are also
useful for monitoring glaucomatous changes. The decline
in spatial contrast sensitivity in patients with glaucoma has
been documented in different tests [15]. The Pelli-Robson
chart produces reliable and reproducible results [16]. The
Pelli-Robson chart tests the spatial frequency of 1 cpd at a
distance of 1 meter. Patients with ocular hypertension and
glaucoma demonstrate contrast sensitivity losses at spatial
frequencies between 0.25 and 8 cpd [17]. Our findings
indicated that contrast sensitivity was worse in glaucoma
patients with moderate defects than in patients with early
defects, especially at low frequencies (<6 cpd), for both
photopic and mesopic luminance with glare lighting. There
was a moderate correlation between worsening visual field
indexes and decreased contrast sensitivity, stronger with the
Pelli-Robson than the CSV1000E test. Our result is consistent
with other findings, such as those by Hawkins et al. [18] and
Wilensky et al. [19], who reported a significant correlation
between themean deviation asmeasured with theHumphrey
perimeter and the Pelli-Robson contrast sensitivity scores
(𝑟 = 0.56, 𝑝 < 0.001, 𝑛 = 127; 𝑟 = 0.59, 𝑝 < 0.001, 𝑛 = 120,
resp.). Others report that contrast sensitivity can be more
affected than high-contrast visual acuity in glaucoma patients
[20, 21]. Although previous studies did not provide enough
evidence to support the use of contrast sensitivity for the early
detection of glaucoma [22, 23], contrast sensitivity correlates
with the perimeter deviation [20, 21] and we believe that
contrast sensitivity in conjunctionwith visual field testingwill
be a promising method of detecting functional changes in
glaucoma patients—even in those with good visual acuity.
Regarding color vision examination, CCI obtained in the
F-D15 and L-D15 tests did not differ among groups. Another
study in patients with primary open angle glaucoma reported
a prevalence of 60% for blue-yellow defects in contrast to
only 3% for red-green defects [24]. Several theories have been
introduced to explain tritan-like defects in glaucoma, such as
a greater susceptibility of blue-yellow sensitive ganglion cells
to IOP-related damage due to their morphology and con-
nectivity to second-order neurons [25]. Our results suggest
that patients with glaucoma manifest signs of deteriorating
color discrimination ability (CCI > 1 in both groups), but we
did not detect differences in color discrimination according
to disease severity or a significant correlation between the
results of color perception testing and visual field indexes.
Moreover, age could have a potentially strong effect on the
deterioration of CCI, as suggested inVingrys andKing-Smith
[26].
Differences in reading ability were also not detected
between groups based on severity in our study, and we
detected no significant correlation with visual field indexes
and reading scores. Several studies have demonstrated
reading impairments in subjects with glaucoma through
performance-based reading testing different from the
Radner-Vissum test [5, 27]. Performance-based reading tests
are commonly measured in strictly controlled conditions,
which do not reflect the typical daily environment of
the patient, and this kind of test could be subject to
wide variability. Glaucoma patients often complain about
problems with reading, especially small print, but the reading
impairment reported in glaucoma patients [28] may be due
to a number of mechanisms, including poor detection of
low-contrast stimuli or inadequate lighting conditions, and
this must be taken into account in clinical practice to suggest
methods to enhance reading ability (creating proper lighting
to optimize contrast or teaching strategies to mitigate
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Table 4: Spearman correlation coefficients (𝑟) between visual field parameters and contrast sensitivity, reading ability, and color vision
measures.
Mean deviation Pattern standard deviation Visual field index
𝑟 𝑝∗ 𝑟 𝑝∗ 𝑟 𝑝∗
BCVA (Snellen) 0.38 <0.001 −0.47 <0.001 0.31 <0.001
Pelli-Robson (F) 0.43 <0.001 −0.48 <0.001 0.38 <0.001
CSV (F) 3 cpd 0.37 <0.001 −0.34 0.008 0.26 0.016
CSV (F) 6 cpd 0.38 <0.001 −0.27 0.036 0.34 0.002
CSV (F) 12 cpd 0.31 0.003 −0.21 0.115 0.33 0.003
CSV (F) 18 cpd 0.32 0.002 −0.12 0.358 0.32 0.005
CSV (M + G) 3 cpd 0.32 0.001 −0.39 <0.001 0.33 <0.001
CSV (M + G) 6 cpd 0.34 <0.001 −0.28 0.032 0.26 0.023
CSV (M + G) 12 cpd 0.25 0.014 −0.25 0.060 0.18 0.096
CSV (M + G) 18 cpd 0.30 0.005 −0.37 0.005 0.22 0.058
LogRad score (RV) −0.05 0.787 0.33 0.184 −0.11 0.593
MRS (RV) 0.28 0.201 −0.39 0.067 0.27 0.654
CCI F-D15 −0.03 0.774 0.001 0.991 0.033 0.774
CCI L-D15 −0.16 0.144 0.21 0.019 −0.18 0.115
∗𝑝: level of statistical significance in Spearman correlations. Bold text shows the statistically significant results (𝑝 < 0.05).
BCVA: best corrected visual acuity; F: photopic luminance; CSV: CSV1000E contrast sensitivity test; M + G: mesopic luminance with glare condition; cpd:
cycles per degree (spatial frequencies); RV: Radner-Vissum reading test; MRS: maximum reading speed; CCI: confusion color index; F-D15: Farnsworth-panel
D15; L-D15: L’Anthony desaturated D15.
fatigue). Considering the fact that in glaucoma visual acuity
is preserved until advanced stages, it is expectable that
reading ability is not affected so much for a long time.
Further studies examining reading ability under dim light
conditions and including patients with severe visual field
defects are required to clarify this.
A possible limitation of our study is the presence of
cataracts. We assume that the influence of cataracts in visual
function measurements in this study was small because we
excluded patients with BCVAworse than 20/30 or if they had
clinically significant lenticular opacity based on the LOCS
III classification [7]. Another limitation of the study was the
difference in group size, which contributed to the data not
conforming to the normal distribution and, consequently, a
reduction in the statistical power that decreased the possibil-
ity of detecting differences.
The findings of the present study indicate that contrast
sensitivity is more decreased as the severity of glaucoma
increases, and this could account for the common complaint
of patients with glaucoma of hazy or blurry vision despite
good visual acuity. Contrast sensitivity was more closely
related than color perception or reading ability with disease
severity.The ability to distinguish contrast plays an important
role in patients’ everyday vision, and several tests are available
to distinguish contrast [29]. The Pelli-Robson chart test is
a low-technology, inexpensive method for measuring spatial
contrast sensitivity, which can detect worsening visual func-
tion in glaucoma patients. We recommended its application
to document worsening visual function in glaucoma patients.
Changes in contrast sensitivity are a potential indicator of the
level of glaucoma damage; however, prospective studies are
required.
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